Compare ADPT & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADPT | UNFI |
|---|---|---|
| Founded | 2009 | 1976 |
| Country | United States | United States |
| Employees | N/A | 25600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2019 | 1996 |
| Metric | ADPT | UNFI |
|---|---|---|
| Price | $14.81 | $44.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $17.78 | ★ $44.71 |
| AVG Volume (30 Days) | ★ 2.2M | 781.0K |
| Earning Date | 04-30-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $276,976,000.00 | N/A |
| Revenue This Year | $3.98 | $0.46 |
| Revenue Next Year | $22.72 | $2.18 |
| P/E Ratio | ★ N/A | $179.44 |
| Revenue Growth | ★ 54.77 | N/A |
| 52 Week Low | $6.71 | $21.27 |
| 52 Week High | $20.76 | $47.59 |
| Indicator | ADPT | UNFI |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 64.39 |
| Support Level | $12.24 | $34.26 |
| Resistance Level | $17.52 | $47.59 |
| Average True Range (ATR) | 0.72 | 1.56 |
| MACD | 0.21 | 0.39 |
| Stochastic Oscillator | 97.21 | 69.05 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.